Security key
H0036K147
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Shares, par value CHF 0.08 per share
- Total 13F shares
- 33,799,357
- Total 13F value
- $682,750,000
- Share change
- +1,006,788
- Put/Call ratio
- 52%
- SEC-reported price per share
- $20.20
- Number of holders
- 50
- Value change
- +$19,180,842
- Number of buys
- 23
- Number of sells
- 24
- Shares outstanding
- 128,459,465
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
50
Top holders
10
ADCT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
ADC Therapeutics SA SEC filings
ADC Therapeutics SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H0036K147
Recent filing periods:
Ownership snapshot
Top reported holders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 6%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
6%
Redmile Group, LLC
5.9%
JPMORGAN CHASE & CO
2.5%
PRICE T ROWE ASSOCIATES INC /MD/
2.2%
ALLIANCEBERNSTEIN L.P.
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
6%
|
$208,390,000
7,672,673 shares
|
— | 30 Sep 2021 |
| Redmile Group, LLC |
13F
Company
|
5.9%
|
$204,497,000
7,529,329 shares
|
— | 30 Sep 2021 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.5%
|
$88,759,000
3,267,986 shares
|
— | 30 Sep 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.2%
|
$76,829,000
2,828,740 shares
|
— | 30 Sep 2021 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
2.1%
|
$72,089,000
2,654,217 shares
|
— | 30 Sep 2021 |
| Vantage Consulting Group Inc |
13F
Company
|
1.3%
|
$45,633,000
1,680,149 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
50
Shares
33,799,357
Rows available
50
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
51
Q4 2021 holders
50
Holder diff
-1
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend